Ibritumomab Intravenous and NovoLog PenFill
Determining the interaction of Ibritumomab Intravenous and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Novoseven
- Ibritumomab Intravenous-NovoSeven RT
- Ibritumomab Intravenous-NovoSeven RT with MixPro injection
- Ibritumomab Intravenous-Novothyrox
- Ibritumomab Intravenous-Noxafil
- Ibritumomab Intravenous-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Ibritumomab Tiuxetan
- NovoLog PenFill-Ibrutinib
- NovoLog PenFill-Ibrutinib Capsules
- NovoLog PenFill-Ibrutinib Tablets
- NovoLog PenFill-Ibu
- NovoLog PenFill-IBU Tablets